Free tool
Rare disease stocks
We cover 11 companies grouped under the Rare disease theme. The median market value in the group is $1.40B. Across the group, the median move over the past trading day is +0.03%. Price change over the past year runs from +47.9% to +328.7% across the middle 80 percent of the group, with a median of +166.8%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
11 of 268 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| ARGX | argenx SE | $65.51B | Large cap | +47.90% | Oct 22, 2026 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $9.00B | Mid cap | +179.08% | Nov 5, 2026 |
| AMLX | Amylyx Pharmaceuticals, Inc. | $4.13B | Mid cap | +292.38% | Nov 5, 2026 |
| ETON | Eton Pharmaceuticals, Inc. | $1.79B | Small cap | +262.38% | Nov 12, 2026 |
| FBRX | Forte Biosciences, Inc. | $1.63B | Small cap | +589.87% | Nov 9, 2026 |
| OMER | Omeros Corporation | $1.40B | Small cap | +328.71% | Nov 12, 2026 |
| AQST | Aquestive Therapeutics, Inc. | $676.51M | Small cap | +40.00% | Nov 4, 2026 |
| XUP.DE | Genfit S.A. | $258.22M | Small cap | +166.82% | Sep 29, 2026 |
| CRDL | Cardiol Therapeutics Inc. | $250.00M | Small cap | +91.07% | Nov 12, 2026 |
| CRDL.TO | Cardiol Therapeutics Inc. | $249.99M | Small cap | +90.38% | Nov 12, 2026 |
| CPIX | Cumberland Pharmaceuticals Inc. | $130.35M | Small cap | +163.82% | Nov 3, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.